We are live on ! Find out more
INFI

Infinity Pharmaceuticals, Inc.
INFI

Delisted

INFI was delisted on the 13th of September, 2023.

Back to rankings

118 hedge funds and large institutions have $606M invested in Infinity Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 29 increasing their positions, 40 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

222% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 9

20% more funds holding

Funds holding: 98 → 118 (+20)

1% more capital invested

Capital invested by funds: $598M → $606M (+$7.53M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

28% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 40

47% less call options, than puts

Call options by funds: $12.9M | Put options by funds: $24.2M

Holders
118
Holders Change
+20
Holders Change %
+20.41%
% of All Funds
3.42%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
29
Increased
29
Reduced
40
Closed
9
Calls
$12.9M
Puts
$24.2M
Net Calls
-$11.3M
Net Calls Change
-$4.94M

Top Buyers

Rank Fund Capital Flow
1
BB
BB Biotech
Switzerland
+$9.71M
2
Millennium Management
Millennium Management
New York
+$8.79M
3
BIM
Bogle Investment Management
Massachusetts
+$5.57M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$4.8M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$3.83M

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$20.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$19.2M
3
BC
Broadfin Capital
New York
-$6.96M
4
Franklin Resources
Franklin Resources
California
-$5.68M
5
Norges Bank
Norges Bank
Norway
-$4.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
51
AllianceBernstein
Tennessee
$1.07M -$40.5K -3,400 -4%
GACM
52
Green Arrow Capital Management
New York
$1.01M +$893K +75,000 New
EWM
53
Evercore Wealth Management
New York
$905K – – –
RFC
54
Russell Frank Company
Washington
$881K +$781K +65,612 New
NCCM
55
Nine Chapters Capital Management
New Jersey
$828K +$555K +46,600 +309%
Wells Fargo
56
Wells Fargo
California
$766K -$33.5K -2,810 -5%
Jacobs Levy Equity Management
57
Jacobs Levy Equity Management
New Jersey
$756K +$671K +56,350 New
PP
58
PDT Partners
New York
$719K +$638K +53,600 New
Swiss National Bank
59
Swiss National Bank
Switzerland
$714K – – –
SEP
60
Sound Energy Partners
Connecticut
$684K +$607K +51,000 New
RhumbLine Advisers
61
RhumbLine Advisers
Massachusetts
$617K -$1.19K -100 -0.2%
ProShare Advisors
62
ProShare Advisors
Maryland
$595K -$105K -8,803 -17%
FAM
63
Formidable Asset Management
Ohio
$578K -$15.5K -1,300 -3%
Renaissance Technologies
64
Renaissance Technologies
New York
$574K -$1.86M -155,800 -78%
CCIA
65
Campbell & Co Investment Adviser
Maryland
$539K +$478K +40,127 New
State Board of Administration of Florida Retirement System
66
State Board of Administration of Florida Retirement System
Florida
$538K – – –
AFG
67
American Financial Group
Ohio
$536K – – –
MLICM
68
Metropolitan Life Insurance Company (MetLife)
New York
$520K – – –
Royal Bank of Canada
69
Royal Bank of Canada
Ontario, Canada
$504K -$4.76K -400 -1%
NFA
70
Nationwide Fund Advisors
Ohio
$503K +$1.11K +93 +0.2%
HCM
71
Highbridge Capital Management
New York
$477K +$423K +35,508 New
VOYA Investment Management
72
VOYA Investment Management
Georgia
$451K – – –
Citadel Advisors
73
Citadel Advisors
Florida
$427K +$379K +31,852 New
AIG
74
American International Group
New York
$426K -$286 -24 -0.1%
DekaBank Deutsche Girozentrale
75
DekaBank Deutsche Girozentrale
Germany
$381K +$9.53K +800 +3%
1 2
3
4 5

INFI Hedge Fund Activity: Q3 2014 in Review

118 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q3 2014, worth a combined $606M — up 1.3% from $598M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new INFI positions and 9 closed out — a net gain of 20 holders — while 29 added to existing stakes and 40 trimmed.

The largest buyer was BB Biotech, adding an estimated $9.71M. The largest seller was Point72 Asset Management, cutting an estimated $20.4M.

  • 118 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q3 2014, up from 98 in Q2 2014.
  • Funds reported $606M of Infinity Pharmaceuticals, Inc. stock for Q3 2014, up 1.3% quarter-over-quarter.
  • 29 funds opened new Infinity Pharmaceuticals, Inc. positions in Q3 2014 and 9 closed out, a net change of +20 holders.
  • The largest Infinity Pharmaceuticals, Inc. buyer in Q3 2014 was BB Biotech, an estimated $9.71M added.
  • The largest Infinity Pharmaceuticals, Inc. seller in Q3 2014 was Point72 Asset Management, an estimated $20.4M sold.

Based on aggregated 13F filings for Q3 2014.